March 2021 • PharmaTimes Magazine • 3


From the editor

This month PharmaTimes presents Alantra’s annual ranking of the fastest growing pharma companies in the UK, and again there is much cause for celebration. As the analysis shows, a relentless focus on innovation and a determination to solve problems hindering patient outcomes are key traits that have helped those at the top shine in a sector that saw average growth of 33% in 2020. Taking top-spot in the ranking, Exscientia has almost quadrupled its revenue in the last two years, a remarkable achievement and even more so considering the current climate. Turn to page 20 for an in-depth look at the other companies reaching new heights and what’s fuelling their success.

Elsewhere, on page 17, John Pinching and three pharma experts discuss the nature of the relationship between the pharma industry and the NHS and the catalysts for a new dynamic between these two giants of healthcare, while on page 28 the team at Veeva outline their expectations for the life sciences industry in 2021.

We also take another look at the microbiome and the growing realisation of its importance in several disease states and promise in the development of new targeted therapies. On page 38, Anthony Finbow describes how the science of microbiomes will increasingly contribute to research outcomes, while on page 40 Dr Tom Williams provides a close look at the relationship between the microbiome and melanoma.

Image

Selina McKee
editor

Image

PharmaTimes Media Ltd,
Mansard House, Church Road,
Little Bookham, Surrey, KT23 3JG
Tel: +44 (0)20 7240 6999
www.pharmatimes.com Twitter: @PharmaTimes

EDITORIAL
Selina McKee / editor
selina.mckee@pharmatimes.com
Karl Equi / executive director
karl.equi@pharmatimes.com   

SALES & MARKETING
Anna Yeardley / business manager
anna.yeardley@pharmatimes.com

SUBSCRIPTIONS/REPRINTS
Digital and paper copies available free to qualifying readers: www.pharmatimes.com/subscribe
Tel: 01372 414 222
subscriptions@pharmatimes.com
Paper subscriptions available at £90.00 UK and £100.00 overseas per annum.

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.

Material may not be reproduced in any form without the publisher’s written permission. © Copyright 2021 PharmaTimes Magazine. All rights reserved. PharmaTimes Magazine is published by PharmaTimes Media Ltd, which is registered as a limited company in England; No 09019637.

IN THE PIPELINE:
APRIL: A new approach to innovation –
is the pharma patent model fit for purpose?
MAY: It’s a virtual world – digital communications and healthcare, where can we go from here?

You can help shape these articles. For more information,
please email Anna Yeardley anna.yeardley@pharmatimes.com